Skip to main content
Sign In

Hematology, Oncology and BMT - Clinical Services


Children’s Hospital Colorado Center for Cancer and Blood Disorders (CCBD) Clinical Program occupies the entire 7th floor of Children’s Hospital Colorado. Facilities include a dedicated inpatient unit with adjacent outpatient clinic and infusion center. There are over 1,000 CCBD inpatient hospital admissions per year and more than 18,000 outpatient visits. The CCBD includes more than 30 MD faculty and midlevel members and is divided into several distinct programs.

Dr. Brian Greffe with patient Kolby Donovan 

The Pediatric Oncology Program provides care to children, adolescents, and young adults with cancer. We have dedicated subspecialty Pediatric Neuro-Oncology (brain tumors). The Brain tumor program was established in 1995 and is led by nationally and internationally known physicians. The Brain Tumor team includes doctors, nurse practitioners, physician assistants, nurses, pharmacists, psychologists, social workers, child life/therapeutic recreation specialists, dieticians, creative art therapist, case managers, schedulers and a family resource specialist. Each patient has a physician in charge of all treatment decisions, and a primary nurse assigned to oversee details of therapy. In addition to standard of care therapy the Neuro-Oncology program offers a wide variety of experimental therapy for hard to treat tumors and Orthopedic Oncology (bone tumor) Programs. The CCBD Experimental Therapeutics Program was established to promote the development and clinical testing of promising new therapies for the treatment of children, adolescents, and young adults with cancers that have not responded well to available treatments or have inadequate curative options. We also have an emphasis on survivorship that includes the H.O.P.E. (Helping Oncology Patients Excel) long-term follow-up clinic and TACTIC (Thriving After Cancer Treatment is Complete) clinic for adult cancer survivors.

The Pediatric Bone Marrow Transplant (BMT) and Cellular Therapy Program at Children's Hospital Colorado was established in 1993. Since that time, the Program has performed over 600 transplants and the team’s efforts have helped to shape the growing role of BMT in treating a variety of serious pediatric disorders. Diseases in which BMT can be used to provide curative treatment range from pediatric cancers to nonmalignant diseases of blood production such as aplastic anemia, thalassemia and sickle cell disease to inherited defects of the immune system and certain genetic disorders of metabolism such as Hurler's syndrome. The Program carries out all types of transplants using stem cells from both autologous (self) and allogeneic (donated; related or unrelated) sources. Technologies in place to utilize stem cells derived from marrow, peripheral blood and cord blood. Cellular therapies include the transfer of gene modified T cells (TCAR) and natural killer (NK) cell infusions. A selection of innovative clinical trials aimed at improving transplant outcomes and expanding diseases that may be helped with BMT are available to patients who wish to participate.

The Pediatric Hematology Program is responsible for the care of patients with primary noncancerous blood disorders, including hemophilia, coagulation disorders that produce excess bleeding or clotting, sickle cell disease, thalassemia, and a variety of other hematologic disorders. Major clinical components include the regional Hemophilia Center and state-funded Sickle Cell Disease Center. The Immuno-Hematology Clinic focuses on disorders of white blood cell function and how the immune system influences blood cell number and function.

Our faculty and staff are also involved with many groups and support programs such as hematology clinical research projects at the HTC and the main campus, as well as ASH (The American Society of Hematology), ASBMT (American Society for Blood and Marrow Transplantation), Butterfly Program, COG (Children’s Oncology Group), Hemophilia Camp, the HOPE Survivorship Program (Helping Oncology Patients Excel), ICON (ITP Consortium of North America), NAPAAC (North American Pediatric Aplastic Anemia Consortium), CHAT (Children’s Hospital-Acquired Thrombosis), Robbie's Friends, Teen and Young Adults support program, Sickle Cell Camp, Wilderness Program and YAPS (Youth and Pet Survivors Program). These groups and programs provide the Hematology, Oncology and Bone Marrow Transplantation faculty, patients and their families with support through camping program events and peer interaction. The faculty and staff involvement ranges from an advisory role to staffing of the various camps.​